Johnson & Johnson (JNJ)
146.62 +0.38 (0.26%)
Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world.
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Overfool.com
Via The Motley Fool · December 12, 2024
Johnson & Johnson Options Trading: A Deep Dive into Market Sentimentbenzinga.com
Via Benzinga · December 13, 2024
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Reportbenzinga.com
ICER's 2023 report highlights five drugs with unsupported price increases, leading to $815 million in excess costs for U.S. payers. Discover key findings and trends.
Via Benzinga · December 13, 2024
Jim Cramer Says This CEO 'Built An Amazing Company,' Recommends Buying Netflixbenzinga.com
When asked about Advanced Micro Devices, Cramer asks: "But can we just remember Lisa Su has built an amazing company?"
Via Benzinga · December 12, 2024
Why NYSE:JNJ is a Top Pick for Dividend Investors.chartmill.com
Exploring JOHNSON & JOHNSON (NYSE:JNJ)'s dividend characteristics.
Via Chartmill · December 9, 2024
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activitybenzinga.com
Via Benzinga · November 21, 2024
Jim Cramer Bullish On Netflix Nearing $1,000 And AMD's 'Cheap' Valuation Despite Nvidia Dominancebenzinga.com
Jim Cramer expressed strong buying conviction for Netflix Inc. during Wednesday's Lightning Round on "Mad Money," as the streaming giant's shares traded near $934 amid broader tech market strength.
Via Benzinga · December 11, 2024
Elon Musk's Net Worth Surpasses Market Cap Of US Giants Like BofA, Johnson & Johnson, Salesforce, Chevron, Coca-Cola And More: Only 25 Companies Have Higher Market Capbenzinga.com
Only 25 listed companies have a higher market capitalization than Elon Musk's skyrocketing net worth.
Via Benzinga · December 11, 2024
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalexbenzinga.com
GSK's Blenrep combo demonstrates significant survival benefits and improved efficacy in relapsed multiple myeloma compared to Darzalex combo.
Via Benzinga · December 10, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · December 10, 2024
Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead.investors.com
The companies held competing events on Sunday to discuss their multiple myeloma treatments.
Via Investor's Business Daily · December 9, 2024
Coca-Cola cs. Procter & Gamble: Which Is the Better Dow Dividend King Stock to Buy Before the End of the Year?fool.com
Via The Motley Fool · December 8, 2024
Top Analyst Reports For Home Depot, Johnson & Johnson & Salesforcetalkmarkets.com
Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc., Johnson & Johnson, and Salesforce, Inc., as well as two micro-cap stocks, Preformed Line Products Co. and Cooper-Standard Holdings Inc.
Via Talk Markets · December 5, 2024
Celebrating innovation happens from the inside out
(BPT) - For more than a century, Johnson & Johnson has been synonymous with innovation in science and medicine by moving the needle in building a world where complex diseases are prevented and cured, treatments are smarter, and solutions are personalized and accessible. Inventions like robotic surgery, tissue engineering, and treatments for cancers and HIV have changed the world forever and improved the patient experience and health and care for all.
Via Brandpoint · December 4, 2024
Ray Dalio's Bridgewater Adds Broadcom, Apple, SMCI In Q3, While Offloading Stake In AI Giant Nvidia And Other Big Tech Companiesbenzinga.com
Bridgewater Associates, the world's biggest hedge fund, sold top AI-linked stocks like Nvidia, Alphabet, Microsoft, Amazon, and Johnson & Johnson.
Via Benzinga · December 3, 2024
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Laterfool.com
Via The Motley Fool · December 1, 2024
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Programbenzinga.com
Bristol Myers Squibb sues HRSA, claiming its rejection of a rebate model for 340B pricing violates federal law. The lawsuit highlights concerns over program abuse and regulatory overreach.
Via Benzinga · November 29, 2024
2 Very Healthy Dividend Stocks to Hold for Decades of Incomefool.com
Via The Motley Fool · November 26, 2024
3 Dividend Stocks That Are Screaming Buys in Novemberfool.com
Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.
Via The Motley Fool · November 23, 2024
2 Unstoppable Dividend Stocks to Buy Now With $500fool.com
Via The Motley Fool · November 23, 2024
2 Dow Jones Dividend Stocks With Yields Above 3% You Can Buy Now and Hold at Least a Decadefool.com
Via The Motley Fool · November 23, 2024
ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.
Via MarketBeat · November 16, 2024